Litigation Challenges Prioritization of Race or Ethnicity in Allocating COVID-19 Therapies
Bill of Health
MARCH 28, 2022
Food & Drug Administration (FDA) encouraged several states to adopt policies that prioritized race or ethnicity in the allocation of monoclonal antibody treatments and oral antivirals for the treatment of SARS-CoV-2. By James Lytle. Recent guidance from the U.S. Emphasis in original.)
Let's personalize your content